市場調查報告書
商品編碼
1371934
2030 年麻醉設備市場預測:按類型、用途、最終用戶和地區分類的全球分析Anesthesia Equipment Market Forecasts to 2030 - Global Analysis By Type, Application, End User and By Geography |
根據 Stratistics MRC 的數據,2023 年全球麻醉器材市場規模為 83 億美元,預計 2030 年將達到 147.7 億美元,預測期內年複合成長率為 8.6%。
一套被稱為麻醉設備的特定醫療工具和儀器用於在手術和其他醫療程序期間提供和監測麻醉。它是安全、準確地向患者給藥氣體或注射等麻醉劑、使患者失去知覺、緩解疼痛、放鬆肌肉的重要設備。麻醉設備一般由調節麻醉劑濃度、流量的裝置及監測氧濃度、血壓、心率等生命指標的裝置結構。
據世界衛生組織稱,癌症是全球第一大死亡原因,預計 2020 年將導致 1,000 萬人死亡。
現代麻醉技術確保精確和處方麻醉劑給藥,確保最佳給藥並減少用藥錯誤的機會。此外,藥物輸送技術的改進,例如患者自控鎮痛裝置和靶控輸液泵,可以根據每個患者的需求進行客製化麻醉劑給藥。因此,這些方面正在推動市場規模的擴大。
該設備價格昂貴,因為開發和製造先進的麻醉設備需要在研究、材料和技術方面進行大量投資,而這些成本通常會轉嫁給醫療保健提供者。此外,預算限制可能會阻止醫療機構和臨床醫生投資最新技術,特別是在資源有限的環境中,從而阻礙市場成長。
麻醉設備發展帶來的技術進步將進一步改善患者照護。透過人工智慧 (AI) 和機器學習 (ML) 演算法的整合實現資料分析、決策支援和預測建模,幫助麻醉師做出更明智的選擇、更有效地提供麻醉並改善患者護理,有助於改善結果。此外,用於麻醉的設備是專門為適應各種手術和患者群體而量身定做的。這使我們能夠靈活地適應各種麻醉治療,包括鎮靜、局部麻醉和全身麻醉。
市場競爭非常激烈,國內外賣家眾多。另一方面,中小企業的產品有限,資金和技術能力也有限。因此,許多供應商在品質、可靠性和研發方面都落後於知名供應商。因此,這些要素預計將在預測期內抑制市場擴張。
COVID-19大流行的疫情對全球經濟和醫療保健系統產生了重大影響。在大流行初期,由於 COVID-19 病例不斷增加,世界各地的醫療機構停止了擇期手術。此外,大流行導致許多人避免去醫院,延誤了手術並嚴重擾亂了患者對慢性病的監測和治療。因此,麻醉設備市場、製造和供應鏈必須應對產品需求不相容以及向最終消費者按時交付設備等挑戰。
由於拋棄式物品對於保持醫療機構的清潔和減少感染傳播至關重要,因此麻醉拋棄式用品領域預計將佔據最大的市場佔有率。例如喉罩、呼吸管路、氣管插管和過濾器。此外,由於它是拋棄式使用,因此交叉污染的風險較小,並且不需要滅菌。因此,病人安全和感染控制變得越來越重要,麻醉設備市場的這一領域正在穩步擴大。
預計心臟病學領域在預測期內年複合成長率最高。心臟麻醉涉及心臟手術和干涉期間麻醉的實施和監測。該領域的設備包括先進的心臟功能監測工具,例如食道心動圖 (TEE) 探頭、心摶出量監視器和心電圖 (ECG)。此外,這些設備對於麻醉師在具有挑戰性的心血管手術期間確保患者安全和準確的麻醉管理至關重要。因此,為了改善心臟病學和心血管醫學領域的患者治療效果和安全性,心臟病領域正在解決與心臟手術相關的特殊要求和困難。
由於受益於北美強大的醫療基礎設施、最先進的醫療設施和大規模手術,北美在預測期內佔據了最大的市場佔有率。此外,現代麻醉系統的採用是由法規遵循和嚴格的安全要求所推動的。人口高齡化和醫療成本上升進一步加速了北美對優質麻醉設備的持續需求。該市場雲集了眾多知名麻醉設備供應商,創新變得愈加重要。因此,這些方面都有助於市場的擴大。
由於對醫療保健基礎設施、嚴格的法規標準和先進麻醉解決方案的需求不斷成長,預計歐洲在預測期內將呈現最高的年複合成長率。歐洲是全球麻醉設備市場中重要且競爭的地區,因為許多歐洲醫療保健系統優先考慮品質和效率。因此,對監護設備和輸送系統等尖端麻醉設備的需求不斷增加。
According to Stratistics MRC, the Global Anesthesia Equipment Market is accounted for $8.30 billion in 2023 and is expected to reach $14.77 billion by 2030 growing at a CAGR of 8.6% during the forecast period. A specific set of medical tools and instruments known as anesthesia equipment is used to deliver and monitor anesthesia during surgical procedures and other medical treatments. These crucial devices that ensure the safe and accurate administration of anesthetic agents, such as gases and injectable drugs, to patients in order to cause unconsciousness, relieve pain, and relax their muscles. In general, anesthesia equipment consists of devices that regulate the concentration and flow of anesthetic chemicals as well as monitors for vital indicators including oxygen levels, blood pressure, and heart rate.
According to the WHO, cancer is the leading cause of death globally and was responsible for an estimated 10 million deaths in 2020.
Modern anesthetic technology allows for accurate and regulated anesthesia drug administration, ensuring optimal dosage and lowering the possibility of medication errors, this result in increased patient comfort and quicker healing times. Additionally, improvements in drug delivery technologies, such as patient-controlled analgesia devices and target-controlled infusion pumps, enable customized anesthetic delivery that is specialized to the needs of each patient. Therefore, these aspects propel the market size.
Advanced anesthetic equipment development and manufacturing demand large investments in research, materials, and technology, the equipment is expensive since these costs are frequently transferred to healthcare providers. Furthermore, budget restrictions may prevent healthcare facilities and clinicians, particularly in environments with limited resources, from making investments in modern technology which hampers the growth of the market.
The advancements in technology brought forth by the ongoing development of anesthetic equipment further enhance patient care. Data analysis, decision support, and predictive modelling are made possible through the integration of artificial intelligence (AI) and machine learning (ML) algorithms, this helps anaesthesiologists make wise choices, deliver anesthesia more effectively, and enhance patient outcomes. Moreover, the equipment used in anesthesia is made to accommodate a variety of operations and patient groups. Thus, it provides flexibility in terms of various anesthetic treatments, such as sedation, regional anesthesia, and general anesthesia.
The market is competitive since there are many local, national, and international sellers. On the other hand, small and medium-sized suppliers have limited financial and technical capabilities in addition to limited product offerings. As a result, in terms of quality, dependability, and R&D, many providers fall short of well-known vendors. Therefore, during the projection period, these factors will restrain market expansion.
The development of the COVID-19 pandemic had a significant effect on the world economy and healthcare system. Early on in the pandemic, healthcare facilities all across the world stopped performing elective procedures because of the rising number of COVID-19 cases. Moreover, due to the pandemic, many people avoided going to hospitals, procedures were delayed, and patient monitoring and chronic illness treatment were severely disrupted. Therefore, the market for anesthetic equipment, the manufacturing and supply chain had to deal with challenges such as incompatible product demand and on-time delivery of devices to end consumers.
The anesthesia disposables segment is estimated to hold the largest share, due to the disposable items which are essential for preserving cleanliness and limiting the spread of infections in medical facilities. Laryngeal masks, breathing circuits, endotracheal tubes, and filters are just a few examples. Moreover, due to their one-time-use design, they pose less of a danger of cross-contamination and don't require sterilization. Therefore, with a growing emphasis on patient safety and infection control, this sector of the anesthetic equipment market is expanding steadily.
The cardiology segment is anticipated to have highest CAGR during the forecast period. Cardiac anesthesia entails the delivery and supervision of anesthesia during heart procedures and interventions. This segment's equipment includes sophisticated heart function monitoring tools like transesophageal echocardiography (TEE) probes, cardiac output monitors, and electrocardiograms (ECGs). Additionally, for anaesthesiologists to guarantee patient security and accurate anesthetic management during challenging cardiac procedures, these instruments are essential. Therefore, in order to improve patient outcomes and safety in the fields of cardiology and cardiovascular medicine, the cardiology sector addresses the special requirements and difficulties connected with cardiac procedures.
North America commanded the largest market share during the extrapolated period owing to the benefits from a strong healthcare infrastructure, cutting-edge medical facilities, and a significant volume of operations across North America. Additionally, the adoption of contemporary anesthetic systems is driven by regulatory compliance and adherence to exacting safety requirements. The constant need for outstanding anesthetic equipment in North America is further fuelled by an aging population and rising healthcare costs. A significant number of well-known suppliers of anesthetic equipment are present in the market, and technical innovation is becoming increasingly important. Therefore, these aspects contribute to the market's expansion.
Europe is expected to witness highest CAGR over the projection period, owing to healthcare infrastructure, stringent regulatory standards, and a rising demand for advanced anesthesia solutions. Europe is a key and competitive region in the worldwide anesthetic equipment market because many European healthcare systems prioritize quality and efficiency. Therefore, this has led to a consistent demand for cutting-edge anaesthetic equipment, including monitoring devices and delivery systems.
Some of the key players in the Anesthesia Equipment Market include: Ambu A/S, B. Braun Melsungen AG, Becton Dickinson and Company, Dragerwerk AG & Co. KGaA, GE HealthCare Technologies, Inc., Getinge AB, Heyer Medical AG, Koninklijke Philips N.V., Medline Industries, Inc., Medtronic PLC, Penlon Ltd., Pentax, SunMed, LLC, Teleflex Incorporated and Ventlab.
In September 2023, Mayo Clinic and GE HealthCare announce a strategic healthcare collaboration for research and product development programs aimed to transform the experience of patients and clinicians in the practice of radiology and the delivery of novel therapies.
In July 2023, The American Society of Anesthesiologists (ASA) announced it has been selected as a 2023 Best and Brightest Companies to Work For in the Nation. This marks the seventh consecutive year the Society has received the designation.
In April 2022, GE Healthcare announced the FDA pre-market approval (PMA) for its End-tidal (Et) Control software for general anesthesia delivery on its Aisys CS2.
Table Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.